These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18337095)

  • 21. Preparation of novel aza-1,7-annulated indoles and their conversion to potent indolocarbazole kinase inhibitors.
    Al-awar RS; Ray JE; Hecker KA; Joseph S; Huang J; Shih C; Brooks HB; Spencer CD; Watkins SA; Schultz RM; Considine EL; Faul MM; Sullivan KA; Kolis SP; Carr MA; Zhang F
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3925-8. PubMed ID: 15225699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: novel agonists for the CB1 receptor.
    Moloney GP; Angus JA; Robertson AD; Stoermer MJ; Robinson M; Wright CE; McRae K; Christopoulos A
    Eur J Med Chem; 2008 Mar; 43(3):513-39. PubMed ID: 17582659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, SAR studies, and pharmacological evaluation of 3-anilino-4-(3-indolyl) maleimides with conformationally restricted structure as orally bioavailable PKCbeta-selective inhibitors.
    Tanaka M; Sagawa S; Hoshi J; Shimoma F; Yasue K; Ubukata M; Ikemoto T; Hase Y; Takahashi M; Sasase T; Ueda N; Matsushita M; Inaba T
    Bioorg Med Chem; 2006 Sep; 14(17):5781-94. PubMed ID: 16762554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of 5-chloro-N-aryl-1H-indole-2-carboxamide derivatives as inhibitors of human liver glycogen phosphorylase a.
    Onda K; Suzuki T; Shiraki R; Yonetoku Y; Negoro K; Momose K; Katayama N; Orita M; Yamaguchi T; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2008 May; 16(10):5452-64. PubMed ID: 18434170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitors of protein kinase C. 1. 2,3-Bisarylmaleimides.
    Davis PD; Hill CH; Lawton G; Nixon JS; Wilkinson SE; Hurst SA; Keech E; Turner SE
    J Med Chem; 1992 Jan; 35(1):177-84. PubMed ID: 1732526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and SAR studies of indole-based MK2 inhibitors.
    Xiong Z; Gao DA; Cogan DA; Goldberg DR; Hao MH; Moss N; Pack E; Pargellis C; Skow D; Trieselmann T; Werneburg B; White A
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1994-9. PubMed ID: 18291646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity relationship of N-methyl-bisindolylmaleimide derivatives as cell death inhibitors.
    Katoh M; Dodo K; Fujita M; Sodeoka M
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3109-13. PubMed ID: 15896957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitors.
    Onda K; Shiraki R; Ogiyama T; Yokoyama K; Momose K; Katayama N; Orita M; Yamaguchi T; Furutani M; Hamada N; Takeuchi M; Okada M; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2008 Dec; 16(23):10001-12. PubMed ID: 18952447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards configurationally stable bisindolylmaleimide cyclophanes: potential tools for investigating protein kinase function.
    Bartlett S; Nelson A
    Chem Commun (Camb); 2004 May; (9):1112-3. PubMed ID: 15116210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new concise synthesis of arcyriacyanin A and its unique inhibitory activity against a panel of human cancer cell line.
    Murase M; Watanabe K; Yoshida T; Tobinaga S
    Chem Pharm Bull (Tokyo); 2000 Jan; 48(1):81-4. PubMed ID: 10705481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions of LY333531 and other bisindolyl maleimide inhibitors with PDK1.
    Komander D; Kular GS; Schüttelkopf AW; Deak M; Prakash KR; Bain J; Elliott M; Garrido-Franco M; Kozikowski AP; Alessi DR; van Aalten DM
    Structure; 2004 Feb; 12(2):215-26. PubMed ID: 14962382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of 4'-substituted bicyclic pyridones as non-steroidal inhibitors of steroid 5alpha-reductase.
    McCarthy AR; Hartmann RW; Abell AD
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3603-7. PubMed ID: 17490876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3.
    Angell RM; Atkinson FL; Brown MJ; Chuang TT; Christopher JA; Cichy-Knight M; Dunn AK; Hightower KE; Malkakorpi S; Musgrave JR; Neu M; Rowland P; Shea RL; Smith JL; Somers DO; Thomas SA; Thompson G; Wang R
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1296-301. PubMed ID: 17194588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of novel inhibitors of extracellular signal-regulated kinase 2 based on the structure-based virtual screening.
    Park H; Bahn YJ; Jeong DG; Woo EJ; Kwon JS; Ryu SE
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5372-6. PubMed ID: 18835158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and pp60c-Src tyrosine kinase inhibitory activities of novel indole-3-imine and amine derivatives substituted at N1 and C5.
    Kiliç Z; Isgör YG; Olgen S
    Arch Pharm (Weinheim); 2009 Jun; 342(6):333-43. PubMed ID: 19475593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular dysfunction in hyperglycemia: is protein kinase C the culprit?
    Gutterman DD
    Circ Res; 2002 Jan; 90(1):5-7. PubMed ID: 11786509
    [No Abstract]   [Full Text] [Related]  

  • 37. Structural analysis of PI3-kinase isoforms: identification of residues enabling selective inhibition by small molecule ATP-competitive inhibitors.
    Zvelebil MJ; Waterfield MD; Shuttleworth SJ
    Arch Biochem Biophys; 2008 Sep; 477(2):404-10. PubMed ID: 18647592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An efficient synthesis and biological study of novel indolyl-1,3,4-oxadiazoles as potent anticancer agents.
    Kumar D; Sundaree S; Johnson EO; Shah K
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4492-4. PubMed ID: 19559607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computer based design, synthesis and biological evaluation of novel indole derivatives as HCV NS3-4A serine protease inhibitors.
    Ismail NS; El Dine RS; Hattori M; Takahashi K; Ihara M
    Bioorg Med Chem; 2008 Sep; 16(17):7877-87. PubMed ID: 18752958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel indole inhibitors of IMPDH from fragments: synthesis and initial structure-activity relationships.
    Beevers RE; Buckley GM; Davies N; Fraser JL; Galvin FC; Hannah DR; Haughan AF; Jenkins K; Mack SR; Pitt WR; Ratcliffe AJ; Richard MD; Sabin V; Sharpe A; Williams SC
    Bioorg Med Chem Lett; 2006 May; 16(9):2539-42. PubMed ID: 16483773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.